News and publishing service for medical and biotechnology related companies
Contact us:
512.354.7000
twitter
facebook
linkedin
News and publishing service for medical and biotechnology related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
Headlines
Nutriband Inc. (NTRB) Reports Double-Digit Revenue Increase, Continued Progress on AVERSA Fentanyl Development
NRx Pharmaceuticals Inc. (NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100
Adageis Allows Healthcare Providers Maximum Value-Based Care Revenue with Simplicity and Visibility
Study Finds Kids with MS Biologically Age Faster Than Those Without It
New Study Shows TTFields Amplify Immune Attack Against Brain Cancer
BioMedNewsBreaks
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at iAccess Alpha Virtual Summer Conference
HeartBeam Inc. (BEAT)
June 23, 2025
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s Priority Voucher for NRX-100 Ketamine Formulation
NRx Pharmaceuticals Inc. (NRXP)
June 23, 2025
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Price Target Raised to $15 Following AVERSA Fentanyl Manufacturing Milestone
Nutriband Inc. (NTRB)
June 23, 2025
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection
HeartBeam Inc. (BEAT)
June 20, 2025
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
Intelligent Bio Solutions Inc. (INBS)
June 18, 2025
View More BioMedNewsBreaks
BioMedWire Articles
How Robotics Technology is Transforming Healthcare
Astiva Health
June 20, 2025
Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation
Nutriband Inc. (NTRB)
June 20, 2025
Soligenix Inc. (NASDAQ: SNGX) Proprietary Therapy Shows Promise in Treatment of Psoriasis
Soligenix Inc. (SNGX)
June 18, 2025
Study Finds the Overall Prevalence of Psoriasis in the US Unchanged
Soligenix Inc. (SNGX)
June 17, 2025
Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behçet’s Disease
Soligenix Inc. (SNGX)
June 17, 2025
View All BioMedWire Articles
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
Official NewsWire Relationships
BioMedWire Currently Accepts
Bitcoin
Bitcoin Cash
Ethereum
Litecoin
USD Coin
Contact us:
512.354.7000